• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.03% Nasdaq Up 0.29%

    Vanda Pharmaceuticals, Inc. (VNDA)

    -NasdaqGM
    12.20 0.03(0.25%) Jan 26, 4:00PM EST
    Add to Portfolio
    Prev Close:12.23
    Open:12.23
    Bid:8.08 x 100
    Ask:13.50 x 3000
    1y Target Est:26.67
    Beta:2
    Earnings Date:Feb 11 - Feb 16 (Est.)
    Day's Range:12.02 - 12.43
    52wk Range:8.34 - 19.25
    Volume:663,981
    Avg Vol (3m):811,747
    Market Cap:413.59M
    P/E (ttm):N/A
    EPS (ttm):-1.68
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    VNDADown 0.25%413.59M
    AZN89.13B
    LLY77.13B
    JNJ286.24B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):9.52
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.63
    Quarterly EPS Est (Dec-14) :-0.20
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):-0.47

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Vanda Pharmaceuticals Inc., a biopharmaceutical company, is engaged in the development and commercialization of pharmaceutical products. Its product portfolio includes HETLIOZ, a product for the treatment of Non-24-Hour Sleep-Wake Disorder; Fanapt... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback